PRQR
ProQR Therapeutics·NASDAQ
--
--(--)
--
--(--)
PRQR fundamentals
ProQR Therapeutics (PRQR) released its earnings on Nov 6, 2025: revenue was 3.38M (YoY -20.96%), missed estimates; EPS was -0.1173 (YoY -5.39%), beat estimates.
Revenue / YoY
3.38M
-20.96%
EPS / YoY
-0.1173
-5.39%
Report date
Nov 6, 2025
EPS
Actual | -0.3511 | -0.0899 | -0.3049 | -0.3181 | -0.2938 | -0.2846 | -0.2548 | -0.2955 | -0.2213 | -0.2201 | -0.3332 | -0.1712 | -0.1192 | -0.1091 | -0.074 | -0.0773 | -0.0971 | -0.0321 | -0.1113 | -0.0932 | -0.1082 | -0.1414 | -0.1173 | ||||||||
Forecast | -0.3757 | -0.3535 | -0.3732 | -0.2988 | -0.2859 | -0.2519 | -0.2383 | -0.2508 | -0.2625 | -0.2239 | -0.2071 | -0.1973 | -0.1272 | -0.121 | -0.0906 | 0.0187 | -0.1186 | -0.1336 | -0.118 | -0.096 | -0.1004 | -0.1414 | -0.1183 | ||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +6.55% | +74.57% | +18.30% | -6.46% | -2.76% | -12.98% | -6.92% | -17.82% | +15.70% | +1.70% | -60.89% | +13.23% | +6.29% | +9.83% | +18.32% | -513.37% | +18.13% | +75.97% | +5.68% | +2.92% | -7.77% | 0.00% | +0.85% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | 302.76K | 9.20M | 324.50K | 300.28K | 117.53K | 288.17K | 1.01M | 271.66K | 1.37M | 1.07M | 936.91K | 1.39M | 709.90K | 1.31M | 1.45M | 6.84M | 4.80M | 6.75M | 4.28M | 4.22M | 4.89M | 4.50M | 3.38M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | 459.19K | 358.26K | 117.27K | 169.29K | 532.02K | 227.42K | 272.30K | 857.90K | 888.19K | 905.28K | 822.20K | 1.02M | 1.43M | 1.33M | 4.89M | 17.43M | 2.82M | 12.28M | 12.33M | 5.17M | 5.71M | 4.50M | 5.92M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -34.07% | +2468.90% | +176.73% | +77.37% | -77.91% | +26.71% | +270.82% | -68.33% | +53.74% | +18.66% | +13.95% | +35.98% | -50.20% | -1.06% | -70.39% | -60.74% | +70.22% | -44.99% | -65.30% | -18.39% | -14.40% | 0.00% | -42.86% |
Earnings Call
You can ask Aime
What is the revenue and EPS growth rate for ProQR Therapeutics year over year?What factors drove the changes in ProQR Therapeutics's revenue and profit?What is ProQR Therapeutics's gross profit margin?What is the market's earnings forecast for ProQR Therapeutics next quarter?What were the key takeaways from ProQR Therapeutics's earnings call?Did ProQR Therapeutics beat or miss consensus estimates last quarter?What guidance did ProQR Therapeutics's management provide for the next earnings period?What were the key takeaways from ProQR Therapeutics’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
